Institutional investors, including Marcum Wealth LLC, increased stakes in Vertex Pharmaceuticals and CVS Health.

Marcum Wealth LLC increased its stake in Vertex Pharmaceuticals by 2.2%, now owning 1,204 shares valued at $560,000. Other institutional investors also added to their positions. Vertex reported a Q2 net loss of $12.83 per share, with $2.65 billion in revenue. CVS Health saw an 8.4% increase in holdings from Pine Haven Investment Counsel, surpassing earnings estimates with $1.83 per share. Institutional investors own 80.66% of CVS stock.